Cite
HARVARD Citation
Rampling, T. et al. (2015). Safety and immunogenicity of the heterologous prime-boost Ebolavirus vaccine regimen CHAD3-EBO Z and MVA-BN® FILO in healthy UK adults. Journal of infection. 71 (6), pp. 688-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rampling, T. et al. (2015). Safety and immunogenicity of the heterologous prime-boost Ebolavirus vaccine regimen CHAD3-EBO Z and MVA-BN® FILO in healthy UK adults. Journal of infection. 71 (6), pp. 688-. [Online].